These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 21813069)

  • 1. Efficacy of switching to adalimumab in a patient with refractory uveitis of Behçet's disease to infliximab.
    Leccese P; Latanza L; D'Angelo S; Padula A; Olivieri I
    Clin Exp Rheumatol; 2011; 29(4 Suppl 67):S93. PubMed ID: 21813069
    [No Abstract]   [Full Text] [Related]  

  • 2. Adalimumab for sight-threatening uveitis in Behçet's disease.
    Mushtaq B; Saeed T; Situnayake RD; Murray PI
    Eye (Lond); 2007 Jun; 21(6):824-5. PubMed ID: 16601736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders.
    Levy-Clarke G; Jabs DA; Read RW; Rosenbaum JT; Vitale A; Van Gelder RN
    Ophthalmology; 2014 Mar; 121(3):785-96.e3. PubMed ID: 24359625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adalimumab for treatment of severe Behçet's uveitis: a retrospective long-term follow-up study.
    Interlandi E; Leccese P; Olivieri I; Latanza L
    Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S58-62. PubMed ID: 25005224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients.
    Calvo-Río V; Blanco R; Beltrán E; Sánchez-Bursón J; Mesquida M; Adán A; Hernandez MV; Hernandez Garfella M; Valls Pascual E; Martínez-Costa L; Sellas-Fernández A; Cordero Coma M; Díaz-Llopis M; Gallego R; Salom D; García Serrano JL; Ortego N; Herreras JM; Fonollosa A; García-Aparicio AM; Maíz O; Blanco A; Torre I; Fernández-Espartero C; Jovani V; Peiteado-Lopez D; Pato E; Cruz J; Fernández-Cid C; Aurrecoechea E; García M; Caracuel MA; Montilla C; Atanes A; Hernandez FF; Insua S; González-Suárez S; Sánchez-Andrade A; Gamero F; Linares L; Romero-Bueno F; García AJ; Almodovar R; Minguez E; Carrasco Cubero C; Olive A; Vázquez J; Ruiz Moreno O; Jiménez-Zorzo F; Manero J; Muñoz Fernández S; Rueda-Gotor J; González-Gay MA
    Rheumatology (Oxford); 2014 Dec; 53(12):2223-31. PubMed ID: 24996907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired resistance to infliximab against uveitis due to Behçet's disease after one year of administration.
    Ito T; Sonoda KH; Hijioka K; Fujimoto T; Ishibashi T
    Jpn J Ophthalmol; 2010 Sep; 54(5):502-4. PubMed ID: 21052918
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical experience with adalimumab in the treatment of ocular Behçet disease.
    Bawazeer A; Raffa LH; Nizamuddin SH
    Ocul Immunol Inflamm; 2010 Jun; 18(3):226-32. PubMed ID: 20482404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of infliximab on the acute attack of uveitis.
    Alokaily F; Alsaleh S; Al-Balawi M; Al-Rashidi S
    Saudi Med J; 2010 Jan; 31(1):82-5. PubMed ID: 20062906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switching to adalimumab is effective in a case of neuro-Behcet's disease refractory to infliximab.
    Leccese P; D'Angelo S; Angela P; Coniglio G; Olivieri I
    Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S102. PubMed ID: 20868587
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of infliximab and adalimumab in the treatment of a patient with severe neuro-Behçet's disease.
    Belzunegui J; López L; Paniagua I; Intxausti JJ; Maíz O
    Clin Exp Rheumatol; 2008; 26(4 Suppl 50):S133-4. PubMed ID: 19026138
    [No Abstract]   [Full Text] [Related]  

  • 11. [Infliximab treatment for Behçet's disease--beginning of the biological drug era].
    Namba K
    Nippon Ganka Gakkai Zasshi; 2010 Feb; 114(2):85-6. PubMed ID: 20187504
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful switching to adalimumab in an infliximab-allergic patient with severe Behçet disease-related uveitis.
    Takase K; Ohno S; Ideguchi H; Uchio E; Takeno M; Ishigatsubo Y
    Rheumatol Int; 2011 Feb; 31(2):243-5. PubMed ID: 19816689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of anti-tumour necrosis factor alpha (infliximab) on sight-threatening uveitis in a patient with Behçet's disease.
    Morris DS; Gavin MP; Sturrock RD
    Adv Exp Med Biol; 2003; 528():557-9. PubMed ID: 12918763
    [No Abstract]   [Full Text] [Related]  

  • 14. Intestinal Behçet's disease: maintenance of remission with adalimumab monotherapy.
    Ariyachaipanich A; Berkelhammer C; Nicola H
    Inflamm Bowel Dis; 2009 Dec; 15(12):1769-71. PubMed ID: 19177427
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of adalimumab in patients with Behçet's disease unsuccessfully treated with infliximab.
    Olivieri I; Leccese P; D'Angelo S; Padula A; Nigro A; Palazzi C; Coniglio G; Latanza L
    Clin Exp Rheumatol; 2011; 29(4 Suppl 67):S54-7. PubMed ID: 21968237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Behcet's refractory uveitis treated successfully by infliximab].
    Mahfoudhi M; Hariz A; Ben Abdelghani K; Turki S; Kheder A
    Tunis Med; 2014 Jan; 92(1):41-2. PubMed ID: 24879172
    [No Abstract]   [Full Text] [Related]  

  • 17. Induction of regulatory T cells by infliximab in Behcet's disease.
    Sugita S; Yamada Y; Kaneko S; Horie S; Mochizuki M
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):476-84. PubMed ID: 20861484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tocilizumab in severe and refractory non-infectious uveitis.
    Papo M; Bielefeld P; Vallet H; Seve P; Wechsler B; Cacoub P; Le Hoang P; Papo T; Bodaghi B; Saadoun D
    Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S75-9. PubMed ID: 25268663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of recalcitrant genital ulcers of Behçet's disease with adalimumab after failure of infliximab and etanercept.
    Olivieri I; D' Angelo S; Padula A; Leccese P; Mennillo GA
    Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S112. PubMed ID: 19796550
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of infliximab on refractory uveitis in Behcet's disease.
    Sayarlioglu M; Cinal A; Topcu N; Demirok A
    Ann Pharmacother; 2004 May; 38(5):901-2. PubMed ID: 15010522
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.